IMMUNOMODULIERENDE AZALIDE

European patent · EP4399216 · In force

Register entry

Publication number
EP4399216
Application number
EP22777846
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 2, 2022
Published
Jul 17, 2024
Granted
Dec 31, 2025
Protection ends at the latest
Sep 1, 2042
Next annual fee due
Sep 30, 2027
IPC classes
C07H 17/08 (2006.01)
A61K 31/7048 (2006.01)
A61P 11/00 (2006.01)
A61P 29/00 (2006.01)
A61P 37/02 (2006.01)
Priority
US 202163241126 P 07.09.2021
PCT application
PCT/US2022/042421 02.09.2022
PCT publication
WO2023/038852 16.03.2023
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Mar 16, 2026

    Agent entered

    Representative
    E. Blum & Co. AG, Hofwiesenstrasse 349, 8050 Zürich

    Published in Swissreg on 16.03.2026

  3. Dec 31, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 31.12.2025

Parties

Inventor

COX, Mark, R.

Kalamazoo, Michigan 49007, US

EWIN, Richard, A.

Kalamazoo, Michigan 49007, US

RESPONDEK, Tomasz

Kalamazoo, Michigan 49007, US

HOT, Imelda

Kalamazoo, Michigan 49007, US

MADDUX, Todd, M.

Kalamazoo, Michigan 49007, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.